[HTML][HTML] Translating the immune microenvironment of thyroid cancer into clinical practice
Thyroid cancer is an excellent model for studying tumor immune microenvironment, as it
often shows local signs of an immune response. The tumor immune microenvironment of …
often shows local signs of an immune response. The tumor immune microenvironment of …
Programmed death-ligand 1 (PD-L1) is a potential biomarker of disease-free survival in papillary thyroid carcinoma: a systematic review and meta-analysis of PD-L1 …
I Girolami, L Pantanowitz, O Mete, M Brunelli… - Endocrine …, 2020 - Springer
The expression of programmed death-ligand 1 (PD-L1) is an established prerequisite for the
administration of checkpoint inhibitor therapy and is of prognostic value in several cancer …
administration of checkpoint inhibitor therapy and is of prognostic value in several cancer …
[PDF][PDF] Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update
A Makker, MM Goel - Endocr Relat Cancer, 2016 - academia.edu
Endometrioid endometrial carcinoma (EEC), also known as type 1 endometrial cancer (EC),
accounts for over 70–80% of all cases that are usually associated with estrogen stimulation …
accounts for over 70–80% of all cases that are usually associated with estrogen stimulation …
[HTML][HTML] PD-1 ligand expression in epithelial thyroid cancers: potential clinical implications
S Ulisse, C Tuccilli, S Sorrenti, A Antonelli… - International journal of …, 2019 - mdpi.com
The new immunotherapy targeting the programmed cell death 1 (PD-1) receptor and its
cognate ligand PD-L1 has renewed hopes of eradicating the most difficult human cancers to …
cognate ligand PD-L1 has renewed hopes of eradicating the most difficult human cancers to …
PD-L1 and IDO1 are expressed in poorly differentiated thyroid carcinoma
Poorly differentiated thyroid carcinoma (PDTC) is an aggressive form of thyroid cancer that
currently has limited effective treatment options. Immune checkpoint inhibitors (ICIs) have …
currently has limited effective treatment options. Immune checkpoint inhibitors (ICIs) have …
Prognostic role of PD-L1 in malignant solid tumors: a meta-analysis
JS Pyo, G Kang, JY Kim - The International journal of …, 2017 - journals.sagepub.com
Purpose The aim of this study was to elucidate the rates and prognostic roles of
programmed cell death ligand 1 (PD-L1) immunohistochemical (IHC) expression in various …
programmed cell death ligand 1 (PD-L1) immunohistochemical (IHC) expression in various …
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer
S Cantara, E Bertelli, R Occhini, M Regoli, L Brilli… - Endocrine, 2019 - Springer
Purpose Anaplastic thyroid carcinoma (ATC) is a rare, highly aggressive form of thyroid
cancer (TC) characterized by an aggressive behavior and poor prognosis, resulting in …
cancer (TC) characterized by an aggressive behavior and poor prognosis, resulting in …
[HTML][HTML] Immune microenvironment of thyroid cancer
H Yin, Y Tang, Y Guo, S Wen - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Thyroid cancer (TC) is a highly heterogeneous endocrine malignancy with an increased
incidence in women than in men. Previous studies regarding the pathogenesis of TC …
incidence in women than in men. Previous studies regarding the pathogenesis of TC …
[HTML][HTML] PD‑L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study
S Cameselle‑García… - Oncology …, 2021 - spandidos-publications.com
Anaplastic thyroid carcinoma (ATC) and poorly differentiated thyroid carcinoma (PDTC)
have limited treatment options, and immune profiling may help select patients for …
have limited treatment options, and immune profiling may help select patients for …
PD-1/PD-L1 expressions in medullary thyroid carcinoma: clinicopathologic and prognostic analysis of Chinese population
Y Bi, X Ren, X Bai, Y Meng, Y Luo, J Cao… - European Journal of …, 2019 - Elsevier
Introduction Few studies have focused on PD-L1 expression in medullary thyroid carcinoma
(MTC). Expressions of PD-1 and PD-L1 and their clinicopathologic and prognostic relevance …
(MTC). Expressions of PD-1 and PD-L1 and their clinicopathologic and prognostic relevance …